 | This article needs additional citations for verification .(October 2022) |
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1929 |
| Headquarters | Barcelona, Spain |
Key people | Staffan Schüberg (CEO), Albert Esteve (Chairman) |
Number of employees | 2,600 (average, 2017) |
| Website | esteve.com |
Esteve is a Spanish international pharmaceutical company headquartered in Barcelona. Since its founding in 1929, Esteve has extended its commercial activity to more than 100 countries around the world.
The company's origins date back to 1929, when Dr. Antoni Esteve i Subirana, researcher and entrepreneur, founded the firm. Now the family-owned company has around 2,900 employees and operates in different countries and continents, through subsidiary companies in Europe and the US and through production centers in Mexico and China, with products directly present in 40 countries and indirectly present, through licensing and distribution agreements, in over 60 countries around the world. [1]
Esteve focuses mainly on two health-related fields: the pharmaceutical field and the active pharmaceutical ingredient field, or fine chemistry. In the pharmaceutical field, Esteve has activities in research and development (R&D) of innovative medicines, particularly in pain and other areas with unmet therapeutic needs, based on both in-house and collaborative R&D programs as well as on innovative formulations. In 2017 for example, Esteve invested in the development of alternative treatments to strong opioids. [2] In the chemical field, the company focuses on the development of new processes, production and commercialization of active pharmaceutical ingredients.
Research and development is the set of innovative activities undertaken by corporations or governments in developing new services or products, and improving existing ones. Research and development constitutes the first stage of development of a potential new service or the production process.
A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance compared to their performance at the time when they were patented drugs. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.
Johnson & Johnson Innovative Medicine is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
In chemistry, fine chemicals are complex, single, pure chemical substances, produced in limited quantities in multipurpose plants by multistep batch chemical or biotechnological processes. They are described by exacting specifications, used for further processing within the chemical industry and sold for more than $10/kg. The class of fine chemicals is subdivided either on the basis of the added value, or the type of business transaction, namely standard or exclusive products.
Almirall, S.A. is a Spanish pharmaceutical company, with headquarters in Barcelona, founded in 1943.
Science and technology in Portugal is mainly conducted within a network of research and development (R&D) units belonging to public universities and state-managed autonomous research institutions. There are also non-state-run research institutions and some private R&D projects developed by companies.
Leadiant Biosciences, formerly known as Sigma-Tau Industrie Farmaceutiche Riunite, was founded in 1957 by research chemist Claudio Cavazza.
Hugo Sigman is an Argentine psychiatrist and business mogul. He is the founder, CEO and—jointly with his wife, biochemist Silvia Gold—the sole owner of Grupo Insud, a business conglomerate with a presence in the fields of pharmaceuticals, agroforestry, cinema, nature and design.
The pharmaceutical industry in Pakistan is strictly regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.
Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide.
Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).
The North East of England Process Industry Cluster (NEPIC) is an economic cluster developed in accordance with Michael Porter's theories and strategies regarding industrial clusters. The chemistry-using sectors in North East England, where more than 1,400 businesses are headquartered in the industry's supply chain, formed this Process Industry Cluster. In the north-east of England, the industry employs approximately 35,000 direct workers and around 190,000 indirect workers, who collectively account for more than one-third of the area's industrial economy. Companies in the cluster produce 35% of the pharmaceuticals and 50% of the petrochemicals used in the UK, making this area the only net exporter of goods from the country. The area has more than £13 billion in exports.
Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.
| International | |
|---|---|
| National | |
 | This Spanish corporation or company article is a stub. You can help Wikipedia by expanding it. |
